CalciMedica Inc.

11/19/2026 | Press release | Distributed by Public on 11/19/2026 15:58

Initial Statement of Beneficial Ownership (Form 3)

FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Lawler Sean Patrick
2. Date of Event Requiring Statement (Month/Day/Year)
11/10/2026
3. Issuer Name and Ticker or Trading Symbol
CalciMedica, Inc. [CALC]
(Last) (First) (Middle)
C/O CALCIMEDICA, INC., 505 COAST S. BLVD, SUITE 300-9
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Accounting Officer
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)
LA JOLLA, CA 92037
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) (1) 11/08/2020 Common Stock 1,177 $33 D
Employee Stock Option (Right to Buy) (1) 04/27/2031 Common Stock 139 $39.95 D
Employee Stock Option (Right to Buy) (1) 06/30/2031 Common Stock 139 $39.95 D
Employee Stock Option (Right to Buy) (1) 08/30/2032 Common Stock 11 $52.1 D
Employee Stock Option (Right to Buy) (2) 03/19/2033 Common Stock 376 $86.7 D
Employee Stock Option (Right to Buy) (1) 03/19/2033 Common Stock 2 $86.7 D
Employee Stock Option (Right to Buy) (3) 05/07/2033 Common Stock 2,401 $16.25 D
Employee Stock Option (Right to Buy) (4) 03/27/2034 Common Stock 4,000 $20.8 D
Employee Stock Option (Right to Buy) (4) 08/26/2034 Common Stock 4,000 $20.8 D
Employee Stock Option (Right to Buy) (5) 04/22/2035 Common Stock 12,000 $7.65 D
Employee Stock Option (Right to Buy) (6) 04/04/2036 Common Stock 6,251 $2.925 D
Employee Stock Option (Right to Buy) (7) 09/23/2036 Common Stock 50,000 $1.74 D

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Lawler Sean Patrick
C/O CALCIMEDICA, INC.
505 COAST S. BLVD, SUITE 300-9
LA JOLLA, CA 92037
Chief Accounting Officer

Signatures

/s/ Sean Patrick Lawler 11/19/2026
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Immediately exercisable.
(2) 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following November 22, 2022.
(3) 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following May 8, 2023.
(4) 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following March 28, 2024.
(5) 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following March 26, 2025.
(6) 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following April 1, 2025.
(7) 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following September 24, 2026.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
CalciMedica Inc. published this content on November 19, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on November 19, 2026 at 21:58 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]